Grant: Discovery Grants Program - Individual
University of Toronto
$72,000.00
Extracellular Vesicles Mediate Cross-Species Transgene Expression
EF 2024-25
Résumé
Background: Extracellular vesicles (EVs) are essentially cell fragments released by almost every cell type in all organisms and are a growing area of research. This is due to the observation that a proportion of EVs carry genetic material such as RNA as cargo. A growing body of literature describes their role in cell-to-cell communication by transferring RNA (messenger RNA, long noncoding RNA) from donor cells to recipient cells. However, there has been no conclusive evidence that such genetic reprogramming occurs in recipient cells because the RNA being expressed could be confused for the same expression of RNA in the recipient cells. It is difficult to distinguish what is expressed due to the RNA cargo versus what is expressed due to the cell's normal processes. To address this, we have performed cross-species adoptive transfer experiments with mouse/human EVs and mouse/human recipient cells in vitro. Our preliminary data has revealed that in mouse to human experiments, mouse EVs carry mRNA that can be translated in human recipient cells. The majority of mRNA was full length and retained the entire coding sequence. Moreover, the length of the transcript did not matter, as both small and large protein sizes were generated. We later determined that most of these proteins had a nuclear function and this was confirmed by immunohistochemistry for mouse specific proteins. This is the first proof that EVs can mediate mRNA cargo delivery to recipient cells to result in translation.
Hypothesis: Our hypothesis is that EVs carry specific subsets of mRNA destined for translation in recipient cells with high translation efficiency.
Methods:
Objective 1) We will continue in vitro experiments in which proteomics and RNA sequencing is performed on mouse and human cell lines and the EVs that they release (mouse embryonic fibroblasts/melanoma and human endothelial cells/prostatic epithelial cells). Different species combinations of EVs+recipient cells will be evaluated as long as there is a mouse to human pairing. We will confirm expression of EV-transgenes via immunohistochemistry of cross-species protein in the recipient (eg., mouse protein in human cells).
Objective 2) We will focus on EV-derived long noncoding RNA (lncRNA) and its impact on the recipient cell's epigenetic profile. Based on the alterations in the epigenetic landscape due to EV treatments, we will then analyze the lncRNA transcripts potentially responsible and perform overexpression experiments to recapitulate gain of function due to the lncRNA(s).
Objective 3) We have developed a unique in vivo model system to determine the efficacy of EV-specific transgene expression. Proteomics and RNA sequencing will be performed in various samples (cell line xenograft, EVs) after treatment or mock injection. These experiments will tell us if EVs are being "sent" from one site and can genetically reprogram another cell type at a distant site of the organism.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2020-05887
Name nom
Leong, Hon
Department département
Biological Sciences Platform
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2020
Award amount
72000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5504
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal physiology and metabolism
Research subject fr
Physiologie et métabolisme des animaux
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Extracellular Vesicles Mediate Cross-Species Transgene Expression
Keywords
extracellular vesicles; microparticles; cell-to-cell communication; mrna; ncrna; transgene expression; cross-species translation; proteomics; rna sequencing; endocytosis
Application summary
Background: Extracellular vesicles (EVs) are essentially cell fragments released by almost every cell type in all organisms and are a growing area of research. This is due to the observation that a proportion of EVs carry genetic material such as RNA as cargo. A growing body of literature describes their role in cell-to-cell communication by transferring RNA (messenger RNA, long noncoding RNA) from donor cells to recipient cells. However, there has been no conclusive evidence that such genetic reprogramming occurs in recipient cells because the RNA being expressed could be confused for the same expression of RNA in the recipient cells. It is difficult to distinguish what is expressed due to the RNA cargo versus what is expressed due to the cell's normal processes. To address this, we have performed cross-species adoptive transfer experiments with mouse/human EVs and mouse/human recipient cells in vitro. Our preliminary data has revealed that in mouse to human experiments, mouse EVs carry mRNA that can be translated in human recipient cells. The majority of mRNA was full length and retained the entire coding sequence. Moreover, the length of the transcript did not matter, as both small and large protein sizes were generated. We later determined that most of these proteins had a nuclear function and this was confirmed by immunohistochemistry for mouse specific proteins. This is the first proof that EVs can mediate mRNA cargo delivery to recipient cells to result in translation.
Hypothesis: Our hypothesis is that EVs carry specific subsets of mRNA destined for translation in recipient cells with high translation efficiency.
Methods:
Objective 1) We will continue in vitro experiments in which proteomics and RNA sequencing is performed on mouse and human cell lines and the EVs that they release (mouse embryonic fibroblasts/melanoma and human endothelial cells/prostatic epithelial cells). Different species combinations of EVs+recipient cells will be evaluated as long as there is a mouse to human pairing. We will confirm expression of EV-transgenes via immunohistochemistry of cross-species protein in the recipient (eg., mouse protein in human cells).
Objective 2) We will focus on EV-derived long noncoding RNA (lncRNA) and its impact on the recipient cell's epigenetic profile. Based on the alterations in the epigenetic landscape due to EV treatments, we will then analyze the lncRNA transcripts potentially responsible and perform overexpression experiments to recapitulate gain of function due to the lncRNA(s).
Objective 3) We have developed a unique in vivo model system to determine the efficacy of EV-specific transgene expression. Proteomics and RNA sequencing will be performed in various samples (cell line xenograft, EVs) after treatment or mock injection. These experiments will tell us if EVs are being "sent" from one site and can genetically reprogram another cell type at a distant site of the organism.